Search Results
Sep 08, 2026, 08:20 ET Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo
comprehensive pharmaceutical and healthcare ecosystem.Fosun Pharma is dedicated to innovation and globalization. The company has established a global R&D innovation system targeting at unmet medical needs. Our strategic focus is on key therapeutic areas including oncology, immunology and inflammation,
More news about: Accro Bioscience (Suzhou) Limited
Sep 08, 2026, 08:17 ET HBM9378/WIN378, an Ultra-Long-Acting Antibody Targeting TSLP, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study
antibody therapeutics in immunology, oncology and other areas. The Company is building a robust portfolio and differentiated pipeline through internal R&D capability, strategic global collaborations in co-discovery and co-development, and selective acquisitions.Our proprietary antibody technology
More news about: Harbour BioMed
Sep 08, 2026, 08:15 ET Bajaj Finance Acquires 5% Stake in TrueFan AI as part of Finserv Intelligence
investments in the start-up ecosystem, and in-house specialists. Drawing on leading global and domestic innovation models, the initiative envisages R&D labs, centres of excellence, venture-led models and Scholars-in-Residence programme for capability building.About Bajaj Finance Ltd.Bajaj
More news about: Bajaj Finance
Sep 08, 2026, 08:12 ET Hizero Wins Three Major IFA 2026 Honours as Global Leader in No-Suction Hard-Surface Cleaning
alternative to traditional hard-floor cleaning using noisy vacuum technology. At the center of the awards is Hizero's latest hero product: the Glide (R700), its first autonomous robot floor cleaner. The Glide was named a 2026 IFA Innovation Award Honoree in the Best in Smart Home category, achieved the
More news about: Hizero
Sep 08, 2026, 08:05 ET Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
conditions, aiming to bring better therapies to patients worldwide. It has one of the broadest renal-focused pipelines and an integrated platform spanning R&D, manufacturing and commercialization. Its portfolio comprises seven investigational drug candidates and one commercialized product, Mircera®. Three
More news about: Alebund Pharmaceuticals
Sep 08, 2026, 08:00 ET Bausch Health i YUN ogłaszają ekspansję na rynek meksykański oraz kolejne rynki regionu EMEA
Ukrainie, w Bułgarii i Kazachstanie.LAVAL (Quebec), 8 września 2026 r. /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), globalne, zdywersyfikowane przedsiębiorstwo farmaceutyczne, oraz YUN, belgijski
More news about: Bausch Health Companies Inc.
Sep 08, 2026, 08:00 ET NIKON IS DEVELOPING FIRMWARE VERSION 2.00 FOR THE NIKON ZR FULL-FRAME SENSOR CAMERA
enabling image rendering tailored to the creator's intent and the tone of the work.Support for focus peaking display during recording in the R3D NE* format, enabling more precise focus confirmation.Firmware version 2.00 is scheduled for release in 2026.Nikon is also developing
More news about: Nikon Inc.
Sep 08, 2026, 08:00 ET OneMain Holdings to Present at Barclays Global Financial Services Conference
www.OneMainFinancial.com.ContactsInvestor Contact:Peter R Poillon, [email protected]
More news about: OneMain Holdings, Inc.
Sep 08, 2026, 08:00 ET North American Operators Investing Heavily in PON Equipment As Fiber Subscribers Continue to Surge, According to Dell'Oro Group
their multi-gig service offerings.Cable operators are modernizing their networks through sustained Remote PHY Device (RPD) and Remote OLT (R-OLT) purchases, with combined revenue for those platforms jumping 63 percent Y/Y.FWA CPE unit shipments declined 12 percent Y/Y, driven largely
More news about: Dell'Oro Group
Sep 08, 2026, 08:00 ET Geotab Ranks No. 11 on Fast Company's Eighth Annual List of the 100 Best Workplaces for Innovators
directly with customers to solve real-world operational challenges.Innovation at Geotab is built on four pillars:R&D at scale: $200M+ invested annually, with more than 800granted patents worldwide.AI for everyone: All 3,400+ employees have access
More news about: Geotab Inc.
Sep 08, 2026, 08:00 ET Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results of SKB378/WIN378 in Asthma, and Initiates Phase 3 Study
as HBM9378).About Kelun-BiotechKelun-Biotech (6990.HK) is a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. Kelun-Biotech focuses on major
More news about: Kelun-Biotech
Sep 08, 2026, 08:00 ET Sanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS®
Patient Information, for more details. MAT-US-2609441-v1.0-09/2026 About SanofiSanofi is an R&D driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. We apply our deep understanding of the
More news about: Sanofi
Sep 08, 2026, 08:00 ET Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026
Brister TS, Duckworth K, et al. Impact of major depressive disorder on comorbidities: a systematic literature review. J Clin Psychiatry. 2022;83(6):21r14328.Cao B, Zhu J, Zuckerman H, et al. Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic
More news about: Johnson & Johnson
Sep 08, 2026, 07:45 ET TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
agonist product candidates, TuHURA is developing TBS-2025, a VISTA inhibiting mAb moving into dose escalation/optimization Phase 1b trial in mutNPM1 r/r AML, a molecularly defined subgroup representing approximately 35% of patients with AML. TuHURA is also leveraging its Delta Opioid Receptor technology
More news about: TuHURA Biosciences, Inc.
Sep 08, 2026, 07:30 ET Quantinuum Finalizes $100 Million CHIPS R&D Award with U.S. Department of Commerce to Advance Trapped-Ion Quantum Computer Manufacturing in the US
The federal funding supports critical R&D and U.S. quantum semiconductor manufacturing capabilities needed to scale fault-tolerant trapped-ion quantum computing.Company partnering with GlobalFoundries to fabricate next-gen ion traps and control electronics, and Monarch
More news about: Quantinuum
Sep 08, 2026, 07:30 ET Quantinuum Finalizes $100 Million CHIPS R&D Award with U.S. Department of Commerce to Advance Trapped-Ion Quantum Computer Manufacturing in the US
The federal funding supports critical R&D and U.S. quantum semiconductor manufacturing capabilities needed to scale fault-tolerant trapped-ion quantum computing.Company partnering with GlobalFoundries to fabricate next-gen ion traps and control electronics, and Monarch
More news about: Quantinuum
Sep 08, 2026, 07:30 ET Quantinuum conclut un accord de 100 millions de dollars avec le département américain du Commerce dans le cadre du programme CHIPS R&D pour soutenir la fabrication d'ordinateurs quantiques à ions piégés aux États-Unis
Ce financement fédéral soutient les activités essentielles de R&D ainsi que les capacités de fabrication américaines de semiconducteurs quantiques nécessaires au développement à grande échelle de l'informatique quantique à ions piégés tolérante aux pannes.L'entreprise
More news about: Quantinuum
Sep 08, 2026, 07:30 ET 퀀티넘, 미국 내 포획 이온 양자 컴퓨터 제조 발전 위해 미국 상무부와 1억 달러 규모 CHIPS R&D 지원금 최종 확정
포획 이온 기반 아키텍처 기업 가운데 유일하게 CHIPS R&D 지원금을 받은 퀀티넘은 업계를 선도하는 오류 수정 충실도를 갖춘 세계 최고 정확도의 상용[1] 컴퓨터를 개발하고 있다.[2] 퀀티넘은 현재 및 미래 양자 컴퓨터의 신뢰성, 반복 재현성 및 확장성을 확보하는 데 기여하기 위해
More news about: Quantinuum
Sep 08, 2026, 07:00 ET Hirain and Arbe Selected by One of the World's Largest Automotive Groups for Level 3 Program Across Multiple Brands
includes Automotive Electronics, R&D Services and Solutions, integrated systems and specialized vehicles, and intelligent transportation solutions to clients worldwide.Headquartered in Beijing, Hirain has built an integrated ecosystem encompassing marketing, R&D, manufacturing, operations, and
More news about: Arbe
Sep 08, 2026, 06:53 ET Spirox lance un système d'inspection des fissures à grande vitesse pour TGV destiné à faciliter l'inspection de grands volumes de substrats en verre
essentielles à la production. Conçu pour répondre aux besoins de la production en grande série, le SP7000G, associé au SP8000G de Spirox, destiné à la R&D et à l'analyse du contrôle qualité, permet d'offrir aux clients des capacités d'inspection et d'analyse sur l'ensemble du substrat plus rapides, plus
More news about: Spirox Corporation